PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9071983-6 1997 Infusion of vasopressin at 160 pg/min produced plasma concentrations of 10.1 +/- 2.1 pmol/l and this led to a significant increase in sodium excretion and a significant decrease in urine flow rate. Sodium 134-140 arginine vasopressin Rattus norvegicus 12-23 9226397-2 1997 The present work investigates whether (1) vasopressin also inhibits sodium intake when injected i.c.v., and (2) the effect of oxytocin and of vasopressin on sodium intake is affected by i.c.v. Sodium 68-74 arginine vasopressin Rattus norvegicus 42-53 9226397-2 1997 The present work investigates whether (1) vasopressin also inhibits sodium intake when injected i.c.v., and (2) the effect of oxytocin and of vasopressin on sodium intake is affected by i.c.v. Sodium 157-163 arginine vasopressin Rattus norvegicus 142-153 9021647-7 1997 These results suggest that central vasopressin is required for the complete development of DOCA-salt hypertension and the mechanism is, in part, due to enhanced sodium intake through the additive effect of central vasopressin and DOCA-salt. Sodium 161-167 arginine vasopressin Rattus norvegicus 35-46 9021647-7 1997 These results suggest that central vasopressin is required for the complete development of DOCA-salt hypertension and the mechanism is, in part, due to enhanced sodium intake through the additive effect of central vasopressin and DOCA-salt. Sodium 161-167 arginine vasopressin Rattus norvegicus 214-225 8943768-10 1996 In this group, sodium excretion increased significantly during vasopressin infusion, and rapidly returned to baseline values when the vasopressin was discontinued. Sodium 15-21 arginine vasopressin Rattus norvegicus 63-74 9044449-0 1997 Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors. Sodium 37-43 arginine vasopressin Rattus norvegicus 9-20 8943768-10 1996 In this group, sodium excretion increased significantly during vasopressin infusion, and rapidly returned to baseline values when the vasopressin was discontinued. Sodium 15-21 arginine vasopressin Rattus norvegicus 134-145 8765464-0 1996 Arginine vasopressin mediates the chloroquine induced increase in renal sodium excretion. Sodium 72-78 arginine vasopressin Rattus norvegicus 9-20 8778224-2 1996 Vasopressin caused a dose-dependent increase in sodium excretion when administered at 40-160 pmol/min. Sodium 48-54 arginine vasopressin Rattus norvegicus 0-11 8258953-0 1993 Enhancement of vascular action of arginine vasopressin by diminished extracellular sodium concentration. Sodium 83-89 arginine vasopressin Rattus norvegicus 43-54 7738468-9 1995 Only the higher rates of infusion of vasopressin and oxytocin significantly increased the clearance of sodium, by 53 +/- 23 and 62 +/- 18% and glomerular filtration rate (GFR) by 23 +/- 4 and 23 +/- 4% respectively. Sodium 103-109 arginine vasopressin Rattus norvegicus 37-48 7977862-1 1994 The present investigations determined the effects of dietary sodium deprivation on the neurohypophysial secretion of arginine vasopressin (AVP) and oxytocin (OT) by rats in response to nonhypotensive hypovolemia induced by subcutaneous injection of 30% polyethylene glycol solution. Sodium 61-67 arginine vasopressin Rattus norvegicus 126-137 8836955-0 1996 Release of vasopressin in response to altered plasma volume and sodium concentrations following pinealectomy in the rat. Sodium 64-70 arginine vasopressin Rattus norvegicus 11-22 8836955-6 1996 Similarly, following infusion of hypertonic saline, the increase in plasma vasopressin per unit increase in plasma sodium was lower in pinealectomized animals than the pineal intact controls. Sodium 115-121 arginine vasopressin Rattus norvegicus 75-86 7864228-5 1995 However, the lines describing the relationship of log plasma vasopressin to plasma volume and plasma sodium in the rats treated with furosemide for 32 h lay to the left of the same relationships in the rats treated for 8 h or the sham-treated controls. Sodium 101-107 arginine vasopressin Rattus norvegicus 61-72 7810534-8 1995 In PNS rats, plasma AVP was significantly higher than in control rats (control 0.77 +/- 0.10 pg/mL v PNS 2.13 +/- 0.42 pg/mL; P < 0.005, n = 12), even though there were no differences in plasma osmolality (control 292.0 +/- 2.0 mOsm/kg H2O v PNS 290.3 +/- 2.5 mOsm/kg H2O; P = NS, n = 12) or serum sodium concentration (control 142.7 +/- 0.7 v PNS 142.1 +/- 1.1; PNS, n = 12). Sodium 301-307 arginine vasopressin Rattus norvegicus 20-23 7977814-4 1994 Sodium excretion rates increased markedly during the infusions of vasopressin in both SHR and DOCA-salt-hypertensive rats but also in their appropriate normotensive controls. Sodium 0-6 arginine vasopressin Rattus norvegicus 66-77 7977814-7 1994 Replacement of the sodium losses that occurred during the vasopressin infusion failed to return pressure toward control levels in SHR but did increase pressure in the DOCA-salt-hypertensive group. Sodium 19-25 arginine vasopressin Rattus norvegicus 58-69 8184959-0 1994 Vasopressin inhibits calcium-coupled sodium efflux system in rat brain. Sodium 37-43 arginine vasopressin Rattus norvegicus 0-11 8258953-1 1993 The present study was undertaken to examine the effects of diminished extracellular sodium concentration on the vascular action of arginine vasopressin (AVP) in cultured rat vascular smooth muscle cells (VSMC). Sodium 84-90 arginine vasopressin Rattus norvegicus 140-151 8261688-0 1993 Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat. Sodium 73-79 arginine vasopressin Rattus norvegicus 47-58 8326257-5 1993 Plasma vasopressin and oxytocin concentrations were significantly elevated throughout dehydration to levels which could be reproduced by acutely increasing plasma sodium and decreasing blood volume to the same extent. Sodium 163-169 arginine vasopressin Rattus norvegicus 7-18 8261688-6 1993 Sodium excretion rates were higher during infusions of vasopressin than during phenylephrine infusions. Sodium 0-6 arginine vasopressin Rattus norvegicus 55-66 8349322-0 1993 Enhancement of intracellular sodium by vasopressin in spontaneously hypertensive rats. Sodium 29-35 arginine vasopressin Rattus norvegicus 39-50 8349322-1 1993 The arginine vasopressin-induced increase in intracellular sodium concentration was augmented in cultured rat vascular smooth muscle cells derived from 12-week-old spontaneously hypertensive rats (SHR) compared with those from 12-week-old normotensive Wistar-Kyoto (WKY) rats. Sodium 59-65 arginine vasopressin Rattus norvegicus 13-24 8349322-3 1993 The calcium-free state did not affect the basal intracellular sodium concentration but completely blocked the arginine vasopressin-induced increase in intracellular sodium concentration in both cell groups. Sodium 165-171 arginine vasopressin Rattus norvegicus 119-130 8349322-7 1993 Pretreatment of both cell groups with a calmodulin antagonist, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, completely blocked arginine vasopressin-induced intracellular alkalinization and increased intracellular sodium concentration. Sodium 220-226 arginine vasopressin Rattus norvegicus 143-154 8349322-9 1993 These findings therefore indicate that the arginine vasopressin-induced increase in intracellular sodium concentration is augmented in vascular smooth muscle cells of SHR mediated through the enhancement of the mobilization of cytosolic free calcium and the activity of sodium-hydrogen exchange, which depends on an increase in V1 receptor number. Sodium 98-104 arginine vasopressin Rattus norvegicus 52-63 8349322-9 1993 These findings therefore indicate that the arginine vasopressin-induced increase in intracellular sodium concentration is augmented in vascular smooth muscle cells of SHR mediated through the enhancement of the mobilization of cytosolic free calcium and the activity of sodium-hydrogen exchange, which depends on an increase in V1 receptor number. Sodium 270-276 arginine vasopressin Rattus norvegicus 52-63 7504728-0 1993 Sodium-evoked, calcium-independent vasopressin release from rat isolated neurohypophysial nerve endings. Sodium 0-6 arginine vasopressin Rattus norvegicus 35-46 8381523-2 1993 Reabsorbtion of sodium through this channel, which is regulated by hormones such as aldosterone and vasopressin, is one of the essential mechanisms involved in the regulation of sodium balance, blood volume and blood pressure. Sodium 16-22 arginine vasopressin Rattus norvegicus 100-111 1529664-6 1992 These results indicate that cerebrospinal fluid is subject to modest chronic and acute changes in osmolality and sodium concentration which may contribute to the osmotic control of AVP secretion. Sodium 113-119 arginine vasopressin Rattus norvegicus 181-184 1490249-0 1992 Role of sodium and water excretion in the antihypertensive effect of vasopressin in the spontaneously hypertensive rat. Sodium 8-14 arginine vasopressin Rattus norvegicus 69-80 1490249-8 1992 Sodium excretion rates increased during the infusions of vasopressin to a greater extent in SHR than in WKY. Sodium 0-6 arginine vasopressin Rattus norvegicus 57-68 1505472-0 1992 Increases in cellular sodium concentration by arginine vasopressin and endothelin in cultured rat glomerular mesangial cells. Sodium 22-28 arginine vasopressin Rattus norvegicus 55-66 1505472-1 1992 The present study was undertaken to determine whether arginine vasopressin (AVP), angiotensin-II, and endothelin (ET) increase the cellular sodium concentration ([Na+]i) in cultured rat glomerular mesangial cells. Sodium 140-146 arginine vasopressin Rattus norvegicus 63-74 1336310-2 1992 These include both the biochemical effect of VP-stimulated adenosine 3",5"-cyclic monophosphate (cAMP) formation in the CCT and physiological effects of VP-mediated sodium and water retention. Sodium 165-171 arginine vasopressin Rattus norvegicus 153-155 1448828-7 1992 RESULTS: The arginine vasopressin V1 receptor antagonist and atrial natriuretic peptide significantly (p < 0.05) reduced water and sodium contents in the posterior edematous regions. Sodium 134-140 arginine vasopressin Rattus norvegicus 22-33 1450929-1 1992 Facial motoneurones of the rat respond to arginine vasopressin by generating a voltage-dependent inward current which is sodium-dependent and is resistant to tetrodotoxin. Sodium 121-127 arginine vasopressin Rattus norvegicus 51-62 1309326-0 1992 pH dependence of inhibition of arginine vasopressin-induced adenosine 3",5"-monophosphate production by cellular sodium depletion in rat renal inner medullary collecting duct cells in culture. Sodium 113-119 arginine vasopressin Rattus norvegicus 40-51 1315019-4 1992 To determine if AVP or aldosterone could alone or together augment sodium transport in the perinatal lung, we studied primary cultures of fetal rat distal lung epithelium in Ussing chambers. Sodium 67-73 arginine vasopressin Rattus norvegicus 16-19 1325505-1 1992 OBJECTIVE AND DESIGN: The present study was designed to determine whether increases in sodium concentration in the cerebrospinal fluid (CSF) play a role in the augmented hypertension induced by long-term salt loading in spontaneously hypertensive rats (SHR), and whether the enhanced arginine vasopressin (AVP) activity and/or the sympathetic nervous system contribute to the increased hypertension. Sodium 87-93 arginine vasopressin Rattus norvegicus 293-304 1868507-4 1991 Upon removal of sodium from the perfusing medium, basal release of VP and OT increased by 3.95 +/- 0.23- and 3.71 +/- 0.22-fold, respectively, followed by a decline to about double the levels in normal (150 mM) sodium (P less than or equal to 0.1). Sodium 16-22 arginine vasopressin Rattus norvegicus 67-69 1410425-4 1992 It is likely that in response to hypertonicity they signal the SON and PVN to release vasopressin and elsewhere to elicit other osmoregulatory responses such as thirst and the excretion of sodium. Sodium 189-195 arginine vasopressin Rattus norvegicus 86-97 1959623-3 1991 This study shows, based on parallel experiments studying [Na+]i, [Ca2+]i and vasopressin secretion, that sodium acts directly to regulate secretion in isolated nerve endings from the rat neurohypophysis. Sodium 105-111 arginine vasopressin Rattus norvegicus 77-88 1868507-4 1991 Upon removal of sodium from the perfusing medium, basal release of VP and OT increased by 3.95 +/- 0.23- and 3.71 +/- 0.22-fold, respectively, followed by a decline to about double the levels in normal (150 mM) sodium (P less than or equal to 0.1). Sodium 211-217 arginine vasopressin Rattus norvegicus 67-69 1868507-6 1991 Compared to neurosecretosomes perfused in normal (150 mM) sodium, omission of sodium from the medium augmented ionomycin-induced VP and OT secretion by 66 +/- 5- and 20 +/- 3-fold, respectively, and A23187-induced secretion was increased 1.3 +/- 0.4- and 1.3 +/- 0.1-fold (P less than or equal to 0.01 for both ionophores). Sodium 78-84 arginine vasopressin Rattus norvegicus 129-131 2139164-3 1990 Intrarenally infused VP produced a significant decrease of glomerular filtration rate (GFR) and an increase of urinary volume and sodium excretion rate. Sodium 130-136 arginine vasopressin Rattus norvegicus 21-23 2078904-6 1990 These results indicate that ILI in the brain may play a role in the secretion of AVP, and that this mechanism could be operated to control a water-sodium balance. Sodium 147-153 arginine vasopressin Rattus norvegicus 81-84 2164912-0 1990 Prompt inhibition of arginine vasopressin-induced cellular adenosine 3",5"-monophosphate production by extracellular sodium depletion in rat renal inner medullary collecting duct cells in culture. Sodium 117-123 arginine vasopressin Rattus norvegicus 30-41 2220406-0 1990 Different effects of short and longer-term arginine vasopressin (AVP) administration on sodium excretion in Brattleboro rats. Sodium 88-94 arginine vasopressin Rattus norvegicus 52-63 2029728-6 1991 In the supraoptic nucleus, vasopressin mRNA levels were significantly decreased in the low-sodium group but were not significantly affected by chloride depletion. Sodium 91-97 arginine vasopressin Rattus norvegicus 27-38 2029728-16 1991 Our results show that chronic sodium, chloride, or potassium depletion differentially affect brain vasopressin mRNA and vasopressin release in young rats. Sodium 30-36 arginine vasopressin Rattus norvegicus 99-110 2029728-16 1991 Our results show that chronic sodium, chloride, or potassium depletion differentially affect brain vasopressin mRNA and vasopressin release in young rats. Sodium 30-36 arginine vasopressin Rattus norvegicus 120-131 1871041-0 1991 Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue. Sodium 31-37 arginine vasopressin Rattus norvegicus 75-86 1854946-3 1991 The important role in the mechanism of the decrease in the water reabsorption in SHR plays the decrease in the content of vasopressin in the blood and urea in the kidney interstitium while in NR a more marked inhibition of the water reabsorption is caused by the decrease in the concentration of both urea and sodium in the kidney layers. Sodium 310-316 arginine vasopressin Rattus norvegicus 122-133 1846120-1 1991 In previous studies we found that vasopressin stimulation of both cyclic AMP (cAMP) formation in cortical collecting tubules (CCT) and sodium reabsorption in isolated perfused kidneys was markedly exaggerated in rats with mineralocorticoid hypertension. Sodium 135-141 arginine vasopressin Rattus norvegicus 34-45 2159725-0 1990 Effect of vasopressin on sodium transport across inner medullary collecting duct. Sodium 25-31 arginine vasopressin Rattus norvegicus 10-21 2182930-4 1990 The evidence further suggest that aldosterone and maybe vasopressin, through their effects on the Na+ channels in the late distal tubule and the collecting duct may be of significance in inducing distal Li+ reabsorption, as seen during severe sodium restriction in rats and dogs. Sodium 243-249 arginine vasopressin Rattus norvegicus 56-67 9691010-1 1998 Experiments were performed to investigate vasopressin type 2 receptor (V2)-mediated renal water reabsorption and the renal expression of the vasopressin-regulated water channel aquaporin-2 (AQP-2) in cirrhotic rats with sodium retention but without ascites. Sodium 220-226 arginine vasopressin Rattus norvegicus 141-152 3625541-15 1986 Arginine vasopressin administered at 12 mu u./min induced plasma hormone levels of 1.54 +/- 0.09 mu u./ml and produced a large antidiuresis and small increase in the rate of sodium excretion. Sodium 174-180 arginine vasopressin Rattus norvegicus 9-20 2810118-6 1989 In the frog skin epithelium, benzylimidazole (10(-4) M) inhibited the vasopressin-stimulated (100 mU/ml) sodium transport and in the toad bladder it decreased the vasopressin-stimulated (5 mU/ml) hydroosmotic flow. Sodium 105-111 arginine vasopressin Rattus norvegicus 70-81 2522287-2 1989 Increasing doses of vasopressin potentiated AP-induced natriuresis in a dose-dependent manner, e.g., sodium excretion during AP administration (290 ng/min) was 0.66 +/- 0.16, 2.02 +/- 0.68, 5.21 +/- 1.38 and 7.08 +/- 1.96 mu eq/min during infusion of 0.00, 0.78, 1.56, and 3.12 ng.kg-1.min-1 of vasopressin, respectively. Sodium 101-107 arginine vasopressin Rattus norvegicus 20-31 2889370-9 1987 It is suggested that vasopressin acts as a vasoconstrictor hormone in conscious sodium-depleted rats when either the renin-angiotensin system or alpha-adrenergic system is inhibited but not when both systems are blocked. Sodium 80-86 arginine vasopressin Rattus norvegicus 21-32 2889551-0 1987 Interaction of vasopressin, angiotensin and alpha-adrenergic system in sodium depletion in the rat. Sodium 71-77 arginine vasopressin Rattus norvegicus 15-26 2889551-6 1987 In sodium depletion, endogenous vasopressin acts as a vasoconstrictor hormone, particularly in the kidney, when either the renin-angiotensin or alpha-adrenergic system is inhibited. Sodium 3-9 arginine vasopressin Rattus norvegicus 32-43 3231703-0 1988 Sodium-depletion-induced contractures in isolated rat vas deferens: possible role of endogenous catecholamines. Sodium 0-6 arginine vasopressin Rattus norvegicus 54-57 3060296-6 1988 The link between plasma AVP and hypertension remains unclear, but it appears likely that it has an important permissive action in the development of sodium-dependent forms of hypertension. Sodium 149-155 arginine vasopressin Rattus norvegicus 24-27 3658129-6 1987 By its presumed reduction of central and peripheral vasopressin release through lowering the cerebrospinal fluid sodium concentration, it may help in decreasing the brain water content. Sodium 113-119 arginine vasopressin Rattus norvegicus 52-63 3625542-0 1986 A synergistic effect of oxytocin and vasopressin on sodium excretion in the neurohypophysectomized rat. Sodium 52-58 arginine vasopressin Rattus norvegicus 37-48 3625542-14 1986 Arginine vasopressin administration (12 microunits/min) inducing plasma levels of 1.24 +/- 0.08 microunit/ml, reduced urine flow by 80% and produced a small increase in sodium excretion. Sodium 169-175 arginine vasopressin Rattus norvegicus 9-20 3625542-18 1986 Combined hormone administration at the lower rate of 5 microunits/min oxytocin and 4 microunits/min vasopressin produced a similar large increment in sodium excretion. Sodium 150-156 arginine vasopressin Rattus norvegicus 100-111 3794328-0 1986 Plasma vasopressin concentration in high sodium renal hypertension. Sodium 41-47 arginine vasopressin Rattus norvegicus 7-18 3792454-0 1986 Arginine vasopressin innoculates against age-related increases in sodium-dependent high affinity choline uptake and discrepancies in the content of temporal memory. Sodium 66-72 arginine vasopressin Rattus norvegicus 9-20 2950253-2 1986 Experimental subjects were rats with hypertension made by chronic infusion of vasopressin on regular intakes of sodium or on sodium loading with 1% NaCl as drinking water. Sodium 112-118 arginine vasopressin Rattus norvegicus 78-89 3794328-7 1986 These results provide further evidence for a contribution of vasopressin to sodium-dependent hypertension. Sodium 76-82 arginine vasopressin Rattus norvegicus 61-72 2875660-6 1986 When the ganglionic blocker pentolinium tartrate was given to sodium-depleted rats the pressor response to AVP was restored to control levels. Sodium 62-68 arginine vasopressin Rattus norvegicus 107-110 2945562-0 1986 Inhibitory roles of the hypothalamic atrial natriuretic polypeptide on the vasopressin release in the sodium-loaded rats. Sodium 102-108 arginine vasopressin Rattus norvegicus 75-86 2945562-2 1986 Sodium loading increased not only the blood pressure but also the urinary output of vasopressin significantly. Sodium 0-6 arginine vasopressin Rattus norvegicus 84-95 2945562-7 1986 These results indicate that the vasopressin production in the hypothalamus is increased, but the release is relatively suppressed in the sodium-loaded rats, and that increased hypothalamic atrial natriuretic polypeptide is involved in the suppression of the vasopressin release and in decreasing their sodium appetite to avoid the high sodium environment. Sodium 137-143 arginine vasopressin Rattus norvegicus 258-269 2945562-7 1986 These results indicate that the vasopressin production in the hypothalamus is increased, but the release is relatively suppressed in the sodium-loaded rats, and that increased hypothalamic atrial natriuretic polypeptide is involved in the suppression of the vasopressin release and in decreasing their sodium appetite to avoid the high sodium environment. Sodium 302-308 arginine vasopressin Rattus norvegicus 32-43 2875660-0 1986 Pressor resistance to vasopressin in sodium depletion, potassium depletion, and cirrhosis. Sodium 37-43 arginine vasopressin Rattus norvegicus 22-33 2875660-4 1986 In conscious rats, the pressor response to graded doses of AVP was reduced in sodium depletion by 27-43% compared with control rats. Sodium 78-84 arginine vasopressin Rattus norvegicus 59-62 2875660-10 1986 We conclude that resistance to the pressor action of AVP in sodium depletion was secondary to resetting of the baroreceptors. Sodium 60-66 arginine vasopressin Rattus norvegicus 53-56 3014903-8 1986 More interestingly, the number of spleen vasopressin binding sites was always lower in Dahl salt-resistant animals than in the Dahl salt-sensitive animals receiving either a sodium deficient or a 1% NaCl or an 8% NaCl-containing diet. Sodium 174-180 arginine vasopressin Rattus norvegicus 41-52 2874211-0 1986 Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Sodium 20-26 arginine vasopressin Rattus norvegicus 97-108 2874211-1 1986 Studies in sodium-dependent models of hypertension have shown that arginine-vasopressin (AVP) plays an important role in the maintenance of blood pressure, predominantly through its vasoconstrictor action. Sodium 11-17 arginine vasopressin Rattus norvegicus 76-87 3026272-9 1986 These receptors are modulated by sodium intake and the difference in receptor number between S and R rats could explain the increased vascular reactivity of S animals to vasopressin. Sodium 33-39 arginine vasopressin Rattus norvegicus 170-181 3766163-5 1986 After sodium loading significant decrease of PRA (-83%), prostaglandin excretion (-34%), insignificant decrease of aldosterone and kallikrein excretion and significant increase of vasopressin (134%) were established. Sodium 6-12 arginine vasopressin Rattus norvegicus 180-191 3099713-0 1986 [Effects of aldosterone and vasopressin on transmembrane efflux of sodium from the arterial wall]. Sodium 67-73 arginine vasopressin Rattus norvegicus 28-39 2856760-0 1985 Role of vasopressin in cardiovascular adaptation to sodium depletion in the conscious rat. Sodium 52-58 arginine vasopressin Rattus norvegicus 8-19 3080471-2 1986 Our previous studies in cortical collecting ducts isolated from rat kidneys have shown that vasopressin increases both sodium absorption and potassium secretion, while bradykinin inhibits sodium absorption without affecting potassium transport. Sodium 119-125 arginine vasopressin Rattus norvegicus 92-103 3703019-0 1986 Sodium-dependence of the saturability of carrier-mediated noradrenaline efflux from noradrenergic neurones in the rat vas deferens. Sodium 0-6 arginine vasopressin Rattus norvegicus 118-121 2856760-1 1985 The hypothesis that vasopressin participates in cardiovascular adaptation to sodium depletion was examined in male Sprague-Dawley rats studied after 6 days (n = 28) or 4 weeks (n = 28) of low sodium diet. Sodium 77-83 arginine vasopressin Rattus norvegicus 20-31 2856760-9 1985 Vasopressin appears to contribute to early but not late cardiovascular adaptation to sodium depletion. Sodium 85-91 arginine vasopressin Rattus norvegicus 0-11 2990759-1 1985 Renal alpha 2-adrenoceptor stimulation by epinephrine infusion reverses cyclic adenosine monophosphate-mediated effects of vasopressin on sodium and water excretion. Sodium 138-144 arginine vasopressin Rattus norvegicus 123-134 4073288-3 1985 AVP secretion in response to osmotic stimuli also was significantly blunted, although sufficient increases in plasma AVP levels did occur, in association with an abnormally high range of plasma sodium concentrations, to allow urinary concentration comparable to control animals. Sodium 194-200 arginine vasopressin Rattus norvegicus 0-3 4064572-7 1985 A ten-fold increase in vasopressin depressed the papillary sodium concentration to a level similar to that in the control group and produced a marked natriuresis. Sodium 59-65 arginine vasopressin Rattus norvegicus 23-34 2990759-3 1985 In the presence of alpha 1-adrenoceptor blockade with prazosin (30 nM) alpha 2-adrenoceptor stimulation with epinephrine reversed the cyclic adenosine monophosphate-mediated effects of vasopressin on sodium (P less than 0.05) and water (P less than 0.05) excretion. Sodium 200-206 arginine vasopressin Rattus norvegicus 185-196 2988346-0 1985 Alpha 2-adrenoceptor antagonism of vasopressin-induced changes in sodium excretion. Sodium 66-72 arginine vasopressin Rattus norvegicus 35-46 4019771-6 1985 Arginine vasopressin (10(-10) M in the bath) caused a sustained fourfold increase in net sodium absorption and a sustained threefold increase in net potassium secretion. Sodium 89-95 arginine vasopressin Rattus norvegicus 9-20 4019771-10 1985 Arginine vasopressin causes a reversible increase in net potassium secretion and net sodium absorption. Sodium 85-91 arginine vasopressin Rattus norvegicus 9-20 2988346-5 1985 Vasopressin (10 microU/ml) produced a significant (P less than 0.05) decrease in both water and sodium excretion. Sodium 96-102 arginine vasopressin Rattus norvegicus 0-11 2988346-7 1985 Alpha 2-Adrenoceptor stimulation with l-epinephrine (28 nM) reversed (P less than 0.05) the effects of vasopressin on water and sodium excretion. Sodium 128-134 arginine vasopressin Rattus norvegicus 103-114 2988346-11 1985 Thus alpha 2-adrenoceptor stimulation antagonized the effects of vasopressin on both water and sodium excretion at the renal level. Sodium 95-101 arginine vasopressin Rattus norvegicus 65-76 7044934-0 1982 Interaction between effects of insulin and vasopressin on renal excretion of water and sodium in rats. Sodium 87-93 arginine vasopressin Rattus norvegicus 43-54 3846407-5 1985 The infusion of vasopressin induced significant increases in circulating levels of vasopressin (248.1 +/- 35.2 pg/ml in vasopressin-infused rats (n = 7) compared to 95.5 +/- 14.6 pg/ml in vehicle-infused rats (n = 7), p less than 0.001) and in weight gain (39.6 +/- 1.3 g in vasopressin-infused rats (n = 7) compared to 29.1 +/- 3.3 g in vehicle-infused rats (n = 7), p less than 0.05), and also sustained decreases in water intake and urine volume, but it did not induce any change in urinary sodium excretion. Sodium 494-500 arginine vasopressin Rattus norvegicus 16-27 3846407-5 1985 The infusion of vasopressin induced significant increases in circulating levels of vasopressin (248.1 +/- 35.2 pg/ml in vasopressin-infused rats (n = 7) compared to 95.5 +/- 14.6 pg/ml in vehicle-infused rats (n = 7), p less than 0.001) and in weight gain (39.6 +/- 1.3 g in vasopressin-infused rats (n = 7) compared to 29.1 +/- 3.3 g in vehicle-infused rats (n = 7), p less than 0.05), and also sustained decreases in water intake and urine volume, but it did not induce any change in urinary sodium excretion. Sodium 494-500 arginine vasopressin Rattus norvegicus 83-94 3846407-5 1985 The infusion of vasopressin induced significant increases in circulating levels of vasopressin (248.1 +/- 35.2 pg/ml in vasopressin-infused rats (n = 7) compared to 95.5 +/- 14.6 pg/ml in vehicle-infused rats (n = 7), p less than 0.001) and in weight gain (39.6 +/- 1.3 g in vasopressin-infused rats (n = 7) compared to 29.1 +/- 3.3 g in vehicle-infused rats (n = 7), p less than 0.05), and also sustained decreases in water intake and urine volume, but it did not induce any change in urinary sodium excretion. Sodium 494-500 arginine vasopressin Rattus norvegicus 83-94 3846407-5 1985 The infusion of vasopressin induced significant increases in circulating levels of vasopressin (248.1 +/- 35.2 pg/ml in vasopressin-infused rats (n = 7) compared to 95.5 +/- 14.6 pg/ml in vehicle-infused rats (n = 7), p less than 0.001) and in weight gain (39.6 +/- 1.3 g in vasopressin-infused rats (n = 7) compared to 29.1 +/- 3.3 g in vehicle-infused rats (n = 7), p less than 0.05), and also sustained decreases in water intake and urine volume, but it did not induce any change in urinary sodium excretion. Sodium 494-500 arginine vasopressin Rattus norvegicus 83-94 6240442-0 1984 Contribution of vasopressin and the sympathetic nervous system in the early phase of high sodium one-kidney renal hypertension. Sodium 90-96 arginine vasopressin Rattus norvegicus 16-27 6208488-0 1984 The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens. Sodium 75-81 arginine vasopressin Rattus norvegicus 139-142 6328407-1 1984 We examined effects of osmolality or sodium concentration on vasopressin induced cyclic AMP generation in the medullary thick ascending limbs isolated from collagenase treated rat kidneys. Sodium 37-43 arginine vasopressin Rattus norvegicus 61-72 6204139-10 1984 Thus AVP may act as an impormediator of volume changes associated with alterations in sodium intake or excretion and thereby affect blood pressure. Sodium 86-92 arginine vasopressin Rattus norvegicus 5-8 6292538-7 1982 The secretion of arginine vasopressin (AVP) increased significantly in SHR with high sodium intake. Sodium 85-91 arginine vasopressin Rattus norvegicus 26-37 2984453-6 1985 Vasopressin-stimulated sodium transport, as reflected by short circuit current (SCC), was inhibited by 18 +/- 6% in the presence of bilirubin (N = 10; P less than 0.02). Sodium 23-29 arginine vasopressin Rattus norvegicus 0-11 2984453-11 1985 These findings show that short-term exposure to bilirubin exerts a tissue-specific effect on the vasopressin-stimulated active transport of sodium but has no effect on the vasopressin-induced fluxes of water and urea. Sodium 140-146 arginine vasopressin Rattus norvegicus 97-108 6090837-0 1984 Biological action and binding sites for vasopressin on the mesenteric artery from normal and sodium-depleted rats. Sodium 93-99 arginine vasopressin Rattus norvegicus 40-51 6090837-5 1984 In sodium-depleted rats we have observed an increase (27%) of the maximal response to AVP with no significant change in ED50 (from 2.8 +/- 1.0 X 10(-8) M to 1.3 +/- 0.2 X 10(-8) M). Sodium 3-9 arginine vasopressin Rattus norvegicus 86-89 6090837-6 1984 On the membrane preparation, the number of binding sites for 3H-AVP was increased from 71 +/- 17 fmole/mg protein (Kd 3.5 +/- 0.5 nM) to 115 +/- 10 fmole/mg protein (Kd 4.8 +/- 0.3 nM) in the sodium-depleted rat by comparison to control animals. Sodium 192-198 arginine vasopressin Rattus norvegicus 64-67 6090837-8 1984 Receptors for AVP are increased in the mesenteric vascular bed by sodium depletion. Sodium 66-72 arginine vasopressin Rattus norvegicus 14-17 6489442-0 1984 GABA agonists inhibit central sodium-induced vasopressin-dependent increases in arterial pressure. Sodium 30-36 arginine vasopressin Rattus norvegicus 45-56 6086885-4 1984 A renal alpha-2 adrenoceptor response was demonstrated by showing that epinephrine could reverse the effect of vasopressin on water and sodium in the presence of beta blockade and alpha-1 destruction by POB. Sodium 136-142 arginine vasopressin Rattus norvegicus 111-122 7124963-1 1982 We investigated the systemic and regional hemodynamic alterations induced in normotensive anephric rats by stimulation of endogenous vasopressin with an acute sodium and fluid load and following vasopressin inhibition with a specific antagonist of its vasoconstricting action. Sodium 159-165 arginine vasopressin Rattus norvegicus 133-144 7105437-4 1982 Thus, two vasopressor mechanisms were stimulated by sodium excess: an acute, transient, partly vasopressin-mediated phase seemed to be followed by a chronic phase mediated through stimulation of central sympathetic neurons. Sodium 52-58 arginine vasopressin Rattus norvegicus 95-106 7300021-4 1981 The lack of the adjusting control system in the brain angiotensin II receptors for sodium balance may be, at least in a part, responsible for the enhancement of vasopressin secretion in the hypertensive rats compared to that in the control rats with high salt intake. Sodium 83-89 arginine vasopressin Rattus norvegicus 161-172 7261551-12 1981 The reduced plasma concentration of vasopressin may account for the decreased plasma and blood volume and the slightly elevated plasma sodium concentration observed in young SHRSP rats. Sodium 135-141 arginine vasopressin Rattus norvegicus 36-47 6973460-6 1981 The relation between the duration of both antidiuresis and sodium excretion and the way of administration was, however, more pronounced in the case of [8-lysine]vasopressin. Sodium 59-65 arginine vasopressin Rattus norvegicus 161-172 6455045-10 1981 HNS released AVP in dose related manner to the osmotic challenge of sodium or glucose, and AVP release was stimulated from HNS by prostaglandin E2, but not by dopamine. Sodium 68-74 arginine vasopressin Rattus norvegicus 13-16 5343354-3 1969 Vasopressin contractions are inhibited by replacement of sodium with mannitol or sucrose, elevation of potassium or magnesium concentrations, the presence of the metabolic inhibitors sodium azide and triethyl tin or tetrodotoxin in the bathing fluid. Sodium 57-63 arginine vasopressin Rattus norvegicus 0-11 6903427-8 1980 In the rat vasopressin-induced changes in kallikrein excretion were positively correlated with changes in sodium and potassium excretion and negatively correlated with changes in free water clearance. Sodium 106-112 arginine vasopressin Rattus norvegicus 11-22 858972-0 1977 Effect of pharmacologic doses of vasopressin on sodium reabsorption in the rat kidney. Sodium 48-54 arginine vasopressin Rattus norvegicus 33-44 858972-5 1977 To reduce the influence of the pressor effect of these doses of vasopressin on the kidney, the aorta was constricted proximal to the renal arteries and this resulted in a decrease in urinary sodium excretion to 2.87 +/- 0.57 micronEq/min. Sodium 191-197 arginine vasopressin Rattus norvegicus 64-75 858972-9 1977 It is concluded that pharmacologic doses of vasopressin inhibit sodium reabsorption in the proximal convoluted tubule as well as in distal portions of the nephron. Sodium 64-70 arginine vasopressin Rattus norvegicus 44-55 858972-10 1977 The magnitude of sodium excretion observed is a function both of vasopressin inhibition of sodium reabsorption and the pressor effect of vasopressin. Sodium 17-23 arginine vasopressin Rattus norvegicus 65-76 858972-10 1977 The magnitude of sodium excretion observed is a function both of vasopressin inhibition of sodium reabsorption and the pressor effect of vasopressin. Sodium 17-23 arginine vasopressin Rattus norvegicus 137-148 858972-10 1977 The magnitude of sodium excretion observed is a function both of vasopressin inhibition of sodium reabsorption and the pressor effect of vasopressin. Sodium 91-97 arginine vasopressin Rattus norvegicus 65-76 187379-3 1976 Sodium and water permeability effects of vasopressin have been shown in toad bladder to have different dose response characteristics. Sodium 0-6 arginine vasopressin Rattus norvegicus 41-52 187379-4 1976 Maximum sodium transport occurs at a lower dose of vasopressin (2 mU/ml) and is believed to be associated with direct permeability effects of the hormone. Sodium 8-14 arginine vasopressin Rattus norvegicus 51-62 1173310-0 1975 Effects of calcium and sodium on vasopressin release in vitro induced by a prolonged potassium stimulation. Sodium 23-29 arginine vasopressin Rattus norvegicus 33-44 1173310-10 1975 In addition they show that a considerable fraction of the vasopressin present in the neurohypophysis can be mobilized during a continued strong stimulation if sodium is omitted from the medium. Sodium 159-165 arginine vasopressin Rattus norvegicus 58-69 638887-0 1978 Effect of the external concentrations of potassium and sodium on the release of (--)-[3H]noradrenaline from the adrenergic nerves of the rat vas deferens. Sodium 55-61 arginine vasopressin Rattus norvegicus 141-144 638887-1 1978 The effect of the external concentrations of sodium and potassium on the nerve-induced release of (--)-[3H]noradrenaline from the adrenergic nerves of the rat vas deferens has been investigated. Sodium 45-51 arginine vasopressin Rattus norvegicus 159-162 69276-1 1976 Administration of pituitrin, vasopressin, and oxytocin to rats during spontaneous micturition increases diuresis and sodium excretion by reducing tubular reabsorption. Sodium 117-123 arginine vasopressin Rattus norvegicus 29-40 14202192-0 1964 THE EFFECTS OF OSMOTIC DIURESIS AND VASOPRESSIN UPON THE DISTRIBUTION OF SODIUM, POTASSIUM AND UREA IN THE RAT KIDNEY. Sodium 73-79 arginine vasopressin Rattus norvegicus 36-47 13424324-0 1957 Effect of purified vasopressin and oxytocin on water and sodium excretion in hypophysectomized rats. Sodium 57-63 arginine vasopressin Rattus norvegicus 19-30 13561335-0 1958 [Effect of vasopressin on the elimination of water load, sodium and potassium in weanling rats]. Sodium 57-63 arginine vasopressin Rattus norvegicus 11-22 32477601-4 2020 In the kidneys of non-anesthetized rats, which received a water load of 2 ml per 100 g of body weight, three effects of vasopressin were revealed: 1) increased reabsorption of water and sodium, 2) increased excretion of potassium ions, and 3) increased excretion of sodium ions. Sodium 186-192 arginine vasopressin Rattus norvegicus 120-131 31955161-12 2021 CONCLUSIONS: We thus have identified novel genes that might regulate vasopressin gene expression in the hypothalamus controlling the magnocellular neurons secretory response to body sodium depletion and consequently hypotonic stress. Sodium 182-188 arginine vasopressin Rattus norvegicus 69-80 32390535-1 2020 Background Arginine vasopressin dependent antidiuresis plays a key role in water-sodium retention in heart failure. Sodium 81-87 arginine vasopressin Rattus norvegicus 20-31 30788735-0 2019 Correlation between Urinary Excretion of Arginine-Vasopressin and Renal Reabsorption of Sodium and Water. Sodium 88-94 arginine vasopressin Rattus norvegicus 50-61 32477601-4 2020 In the kidneys of non-anesthetized rats, which received a water load of 2 ml per 100 g of body weight, three effects of vasopressin were revealed: 1) increased reabsorption of water and sodium, 2) increased excretion of potassium ions, and 3) increased excretion of sodium ions. Sodium 266-272 arginine vasopressin Rattus norvegicus 120-131 30788735-4 2019 It was found that urinary excretion of arginine-vasopressin directly correlated with reabsorption of solute-free water and renal sodium excretion. Sodium 129-135 arginine vasopressin Rattus norvegicus 48-59 26791475-0 2016 Role of Vasopressin in the Regulation of Renal Sodium Excretion: Interaction with Glucagon-Like Peptide-1. Sodium 47-53 arginine vasopressin Rattus norvegicus 8-19 26791475-7 2016 It was hypothesised that the basis for the fast elimination of excess sodium following an oral NaCl load could be the involvement of GLP-1 in osmoregulation combined with vasopressin. Sodium 70-76 arginine vasopressin Rattus norvegicus 171-182 26791475-9 2016 It was also shown that vasopressin at doses of 1-10 mug/kg and the selective V1a agonist (1 mug/kg) induced an increase in sodium fractional excretion to 10 +- 2% and 8 +- 2%, respectively. Sodium 123-129 arginine vasopressin Rattus norvegicus 23-34 26791475-11 2016 These data suggest that GLP-1 combined with vasopressin could be involved in the regulation of sodium balance in the hyperosmolar state as a result of NaCl loading. Sodium 95-101 arginine vasopressin Rattus norvegicus 44-55 24623760-5 2014 We also show that CREB3L1 mRNA levels correlate with AVP transcription level in SONs and PVNs following sodium depletion, and as a consequence of diurnal rhythm in the suprachiasmatic nucleus. Sodium 104-110 arginine vasopressin Rattus norvegicus 53-56 26791475-12 2016 Vasopressin regulates the reabsorption of a significant portion of filtered sodium in the distal segment of the nephron and modulates the natriuretic effect of GLP-1. Sodium 76-82 arginine vasopressin Rattus norvegicus 0-11 26403564-0 2016 Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats. Sodium 50-56 arginine vasopressin Rattus norvegicus 0-11 25043186-1 2014 Homeostatic control of extracellular fluid osmolality in rats requires a parallel excitation of vasopressin (VP) and oxytocin (OT) neurosecretory neurons by osmoreceptor afferents to regulate the amount of water and sodium in the urine under normal conditions. Sodium 216-222 arginine vasopressin Rattus norvegicus 96-107 25043186-1 2014 Homeostatic control of extracellular fluid osmolality in rats requires a parallel excitation of vasopressin (VP) and oxytocin (OT) neurosecretory neurons by osmoreceptor afferents to regulate the amount of water and sodium in the urine under normal conditions. Sodium 216-222 arginine vasopressin Rattus norvegicus 109-111 22700868-9 2012 This observation indicates a beneficial role of vasopressin in AFC by up-regulating active sodium transport. Sodium 91-97 arginine vasopressin Rattus norvegicus 48-59 24103391-0 2013 GABAergic excitation of vasopressin neurons: possible mechanism underlying sodium-dependent hypertension. Sodium 75-81 arginine vasopressin Rattus norvegicus 24-35 23175803-0 2013 Variation in sodium current amplitude between vasopressin and oxytocin hypothalamic supraoptic neurons. Sodium 13-19 arginine vasopressin Rattus norvegicus 46-57 23175803-1 2013 Biophysical characteristics of tetrodotoxin-sensitive sodium (Na(+)) currents were studied in vasopressin (VP) and oxytocin (OT) supraoptic neurons acutely isolated from rat hypothalamus. Sodium 54-60 arginine vasopressin Rattus norvegicus 94-105 23835093-6 2013 V1a agonist (Phe(2)-Ile(3)-Orn(8)-vasopressin) reproduced the renal effects of dAVT on sodium and potassium excretion but not on water reabsorption. Sodium 87-93 arginine vasopressin Rattus norvegicus 34-45 23532834-3 2013 The subject of this study was a search for vasopressin and vasotocin analogues with selective effects on renal water, sodium and potassium excretion. Sodium 118-124 arginine vasopressin Rattus norvegicus 43-54 21468191-1 2010 When the concentration of sodium (Na(+)) in arterial plasma (P(Na)) declines sufficiently to inhibit the release of vasopressin, water will be excreted promptly when the vast majority of aquaporin 2 water channels (AQP2) have been removed from luminal membranes of late distal nephron segments. Sodium 26-32 arginine vasopressin Rattus norvegicus 116-127 20663845-0 2011 Medial septal area ANG II receptor subtypes in the regulation of urine and sodium excretion induced by vasopressin. Sodium 75-81 arginine vasopressin Rattus norvegicus 103-114 20663845-1 2011 INTRODUCTION: The present study was designed to determine the effects of selective antagonists of angiotensin II receptor types AT(1) and AT(2) on the flow of urine and sodium excretion induced by arginine vasopressin (AVP). Sodium 169-175 arginine vasopressin Rattus norvegicus 206-217 20933582-4 2011 In the brainstem, vasopressin can excite facial motoneurons by generating a sustained inward current which is sodium-dependent, tetrodotoxin-insensitive and voltage-gated. Sodium 110-116 arginine vasopressin Rattus norvegicus 18-29 15585668-1 2005 Vasopressin and ANG II, which are known to play a major role in renal water and sodium reabsorption, are mainly coupled to the cAMP/PKA and phosphoinositide pathways, respectively. Sodium 80-86 arginine vasopressin Rattus norvegicus 0-11 19076265-4 2009 Administration of AVP increased sodium excretion. Sodium 32-38 arginine vasopressin Rattus norvegicus 18-21 19076265-5 2009 Pretreatment with V(2) or V(1a) antagonists decreased, and Conivaptan abolished, the sodium excretion induced by AVP. Sodium 85-91 arginine vasopressin Rattus norvegicus 113-116 17567721-8 2007 In experiment 2, the hypothesis that prior experience with central VP would cross-sensitize rats to drinking hypertonic sodium (NaCl) solutions was tested. Sodium 120-126 arginine vasopressin Rattus norvegicus 67-69 17567721-12 2007 This pattern of cross-sensitization links central VP signaling, amphetamine, and sodium deficiency, and therefore it may play a role in the cross-sensitization between sodium appetite and amphetamines. Sodium 81-87 arginine vasopressin Rattus norvegicus 50-52 17940875-1 2008 Arginine vasopressin (AVP) is known to a neuropeptide that plays important roles in water conservation, sodium homeostasis, and in the regulation of serum osmolality. Sodium 104-110 arginine vasopressin Rattus norvegicus 9-20 17940875-1 2008 Arginine vasopressin (AVP) is known to a neuropeptide that plays important roles in water conservation, sodium homeostasis, and in the regulation of serum osmolality. Sodium 104-110 arginine vasopressin Rattus norvegicus 22-25 19169968-5 2008 Since both vasopressin and oestrogen have been reported to inhibit ion fluxes essential for the adaptation of the brain to the lowering of serum sodium concentration, we sought to study the effect of acute and chronic hyponatraemia or hyponatraemia associated with vasopressin on brain morphology in male and female rats. Sodium 145-151 arginine vasopressin Rattus norvegicus 11-22 17573101-0 2007 Vasopressin and angiotensin receptors of the medial septal area of the brain in the control of thirst and salt appetite induced by vasopressin in water-deprived and sodium-depleted rats. Sodium 165-171 arginine vasopressin Rattus norvegicus 0-11 17573101-2 2007 A stainless steel cannula was implanted into the medial septal area (MSA) of male Holtzman rats AVP injection enhanced water and sodium intake in a dose-dependent manner. Sodium 129-135 arginine vasopressin Rattus norvegicus 96-99 17573101-3 2007 Pretreatment with V(1) antagonist injected into the MSA produced a dose-dependent reduction, whereas prior injection of V(2) antagonist increased, in a dose-dependent manner, the water and sodium responses elicited by the administration of AVP. Sodium 189-195 arginine vasopressin Rattus norvegicus 240-243 17573101-4 2007 Both AT(1) and AT(2) antagonists administered into the MSA elicited a concentration-dependent decrease in water and sodium intake induced by AVP, while simultaneous injection of the two antagonists was more effective in decreasing AVP responses. Sodium 116-122 arginine vasopressin Rattus norvegicus 141-144 17573101-5 2007 These results also indicate that the increase in water and sodium intake induced by AVP was mediated primarily by MSA AT(1) receptors. Sodium 59-65 arginine vasopressin Rattus norvegicus 84-87 12182943-0 2002 Sodium deficiency enhances the behavioral responses to centrally administered vasopressin in rats. Sodium 0-6 arginine vasopressin Rattus norvegicus 78-89 12535156-6 2003 The enhancement of plasma vasopressin responses was independent of plasma sodium concentrations or changes in blood pressure. Sodium 74-80 arginine vasopressin Rattus norvegicus 26-37 15960298-0 2005 Enhanced pressor response to centrally administered vasopressin in WKY rats on high sodium diet. Sodium 84-90 arginine vasopressin Rattus norvegicus 52-63 15003832-0 2004 Effects of angiotensin and vasopressin V(1) receptors on water and sodium intake induced by injection of vasopressin into lateral septal area. Sodium 67-73 arginine vasopressin Rattus norvegicus 105-116 15003832-5 2004 Water and sodium intake were measured at 0.25, 0.5, 1.0 and 2.0 h. Injection of AVP reduced the water and sodium ingestion vs. control (0.15 M saline). Sodium 10-16 arginine vasopressin Rattus norvegicus 80-83 15003832-5 2004 Water and sodium intake were measured at 0.25, 0.5, 1.0 and 2.0 h. Injection of AVP reduced the water and sodium ingestion vs. control (0.15 M saline). Sodium 106-112 arginine vasopressin Rattus norvegicus 80-83 12182943-1 2002 The ability of sodium deficiency to stimulate vasopressin (VP) release was examined by determining if sodium deficiency sensitizes the animal to the behavioral disruption caused by intraventricular injections of VP. Sodium 102-108 arginine vasopressin Rattus norvegicus 59-61 12182943-2 2002 In sodium-replete rats, intraventricular injections of 50 ng VP on Day 1 had no effect on behavior, but this dose elicited abnormal behaviors (barrel rolls, hind-limb extensions) when administered on Day 2, indicating a sensitization phenomenon. Sodium 3-9 arginine vasopressin Rattus norvegicus 61-63 12182943-1 2002 The ability of sodium deficiency to stimulate vasopressin (VP) release was examined by determining if sodium deficiency sensitizes the animal to the behavioral disruption caused by intraventricular injections of VP. Sodium 15-21 arginine vasopressin Rattus norvegicus 46-57 12182943-3 2002 In separate experiments, the first intraventricular injection of 50 ng VP in sodium-deficient but not in sodium-replete rats also elicited barrel rotations followed by hind-limb extension. Sodium 77-83 arginine vasopressin Rattus norvegicus 71-73 12182943-1 2002 The ability of sodium deficiency to stimulate vasopressin (VP) release was examined by determining if sodium deficiency sensitizes the animal to the behavioral disruption caused by intraventricular injections of VP. Sodium 15-21 arginine vasopressin Rattus norvegicus 59-61 12182943-4 2002 Intraventricular injection of VP also disrupted motor behavior in sodium-replete rats that had multiple prior experiences with sodium deficiency but not in naive rats. Sodium 66-72 arginine vasopressin Rattus norvegicus 30-32 12182943-4 2002 Intraventricular injection of VP also disrupted motor behavior in sodium-replete rats that had multiple prior experiences with sodium deficiency but not in naive rats. Sodium 127-133 arginine vasopressin Rattus norvegicus 30-32 12182943-5 2002 These results show that sodium deficiency can mimic the effect of central injections of VP in sensitizing the brain to the behavioral effects of exogenous VP. Sodium 24-30 arginine vasopressin Rattus norvegicus 88-90 12072411-1 2002 The present study was intended to determine whether the long-term V2 receptor-mediated effects of vasopressin on sodium reabsorption in the renal collecting duct is an aggravating factor in salt-sensitive hypertension. Sodium 113-119 arginine vasopressin Rattus norvegicus 98-109 12182943-5 2002 These results show that sodium deficiency can mimic the effect of central injections of VP in sensitizing the brain to the behavioral effects of exogenous VP. Sodium 24-30 arginine vasopressin Rattus norvegicus 155-157 12182943-6 2002 This suggests that sodium deficiency induces the central release of VP. Sodium 19-25 arginine vasopressin Rattus norvegicus 68-70 11893630-2 2002 Lateral ventricular injections of 100 ng and 1 microg VP caused barrel rotations and a dramatic decrease in NaCl intake by sodium-deficient rats and suppressed sucrose intake. Sodium 123-129 arginine vasopressin Rattus norvegicus 54-56 11711512-0 2001 Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung. Sodium 53-59 arginine vasopressin Rattus norvegicus 20-31 11998688-0 2002 Integration of sodium and osmosensory signals in vasopressin neurons. Sodium 15-21 arginine vasopressin Rattus norvegicus 49-60 11711512-1 2001 Vasopressin is known to acutely stimulate sodium transport in the renal collecting duct. Sodium 42-48 arginine vasopressin Rattus norvegicus 0-11 11711512-12 2001 This study shows that vasopressin increases sodium transport in the renal collecting duct and probably in the lung, through a differential transcriptional regulation of ENaC subunits. Sodium 44-50 arginine vasopressin Rattus norvegicus 22-33 11573975-2 2001 Classic studies, utilizing isolated perfused tubules, have revealed that vasopressin increases sodium reabsorption in the kidney thick ascending limb and the collecting duct. Sodium 95-101 arginine vasopressin Rattus norvegicus 73-84 11158210-3 2001 Thus, the hypothesis was that the abundance of one or more of the sodium transporters of the distal tubule (a site for fine tuning of sodium balance) would be altered during vasopressin escape. Sodium 66-72 arginine vasopressin Rattus norvegicus 174-185 11158210-13 2001 These data suggest that several distal sodium reabsorptive mechanisms are upregulated during vasopressin escape; this may help to attenuate the developing hyponatremia resulting from water loading when vasopressin levels are inappropriately elevated. Sodium 39-45 arginine vasopressin Rattus norvegicus 93-104 11158210-13 2001 These data suggest that several distal sodium reabsorptive mechanisms are upregulated during vasopressin escape; this may help to attenuate the developing hyponatremia resulting from water loading when vasopressin levels are inappropriately elevated. Sodium 39-45 arginine vasopressin Rattus norvegicus 202-213 10026831-2 1998 With the onset of vasopressin escape, water excretion increases despite sustained administration of vasopressin, allowing water balance to be re-established and the serum sodium to be stabilized at a steady, albeit decreased, level. Sodium 171-177 arginine vasopressin Rattus norvegicus 18-29 10894786-1 2000 Sodium transport is increased by vasopressin in the cortical collecting ducts of rats and rabbits. Sodium 0-6 arginine vasopressin Rattus norvegicus 33-44 10894786-6 2000 These changes are too slow to play a major role in the short-term action of vasopressin to stimulate sodium reabsorption in the collecting duct. Sodium 101-107 arginine vasopressin Rattus norvegicus 76-87 10706418-3 2000 bolus or short-term infusion) of AVP to rats, the relationship between blood concentrations and its effect on both mean arterial pressure (hemodynamic effect) and urinary sodium concentration (anti-diuretic effect) was described on the basis of an integrated pharmacokinetic-pharmacodynamic (PK-PD) model. Sodium 171-177 arginine vasopressin Rattus norvegicus 33-36 10556530-1 1999 The classical short-term effect (within minutes) of arginine vasopressin (AVP) consists in increasing sodium, chloride and water transport in kidney cells. Sodium 102-108 arginine vasopressin Rattus norvegicus 61-72 10556530-1 1999 The classical short-term effect (within minutes) of arginine vasopressin (AVP) consists in increasing sodium, chloride and water transport in kidney cells. Sodium 102-108 arginine vasopressin Rattus norvegicus 74-77 10026831-2 1998 With the onset of vasopressin escape, water excretion increases despite sustained administration of vasopressin, allowing water balance to be re-established and the serum sodium to be stabilized at a steady, albeit decreased, level. Sodium 171-177 arginine vasopressin Rattus norvegicus 100-111 9366557-1 1997 Arginine vasopressin (AVP) and corticosteroid hormones are involved in sodium reabsorption regulation in the renal collecting duct. Sodium 71-77 arginine vasopressin Rattus norvegicus 9-20 9407070-0 1997 Transcriptional regulation of sodium transport by vasopressin in renal cells. Sodium 30-36 arginine vasopressin Rattus norvegicus 50-61 9374816-1 1997 Recent studies in rats suggest that vasopressin and the resulting urinary concentrating activity reduce the capacity of the kidney to excrete sodium. Sodium 142-148 arginine vasopressin Rattus norvegicus 36-47